Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Differences between Acute-onset Chronic Inflammatory Demyelinating Polyneuropathy (A-CIDP) and Acute Inflammatory Demyelinating Polyneuropathy (AIDP) in adult patients.
Neuromuscular and Clinical Neurophysiology (EMG)
P1 - (-)
436
Authors/Disclosures
Lucas Alessandro, Sr., MD (FLENI)
PRESENTER
Dr. Alessandro has nothing to disclose.
No disclosure on file
Miguel Wilken, MD (Raul Carrea Institute for Neurological Research (FLENI)) No disclosure on file
Luis Querol, MD, PhD (Hospital de la Santa Creu i Sant Pau) Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. The institution of Dr. Querol has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. The institution of Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ArgenX. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Querol has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Querol has received research support from GBS-CIDP Foundation International. The institution of Dr. Querol has received research support from Grifols. The institution of Dr. Querol has received research support from ISCIII. The institution of Dr. Querol has received research support from CIBERER. The institution of Dr. Querol has received research support from UCB.
Mariano Marrodan, MD (Institute for Neurological Research Raul Carrea. Fleni) Dr. Marrodan has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Marrodan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck, Astra Zeneca, Gador, Biogen, Roche and Novartis.
Alberto D. Rivero, MD No disclosure on file
Fabio Adrian Barroso, MD Fabio Adrian Barroso, MD has nothing to disclose.
Mauricio F. Farez, MD (FLENI) Dr. Farez has nothing to disclose.